XTX Topco Ltd Has $481,000 Holdings in Indivior PLC (NASDAQ:INDV)

XTX Topco Ltd increased its position in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 123.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,437 shares of the company's stock after acquiring an additional 27,906 shares during the quarter. XTX Topco Ltd's holdings in Indivior were worth $481,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in INDV. GF Fund Management CO. LTD. purchased a new stake in shares of Indivior during the 4th quarter worth about $36,000. Lazard Asset Management LLC bought a new stake in Indivior in the fourth quarter worth approximately $57,000. Schaper Benz & Wise Investment Counsel Inc. WI acquired a new position in shares of Indivior during the 1st quarter worth $95,000. Cannon Global Investment Management LLC bought a new position in shares of Indivior during the 1st quarter valued at $95,000. Finally, Stifel Financial Corp lifted its stake in shares of Indivior by 24.0% in the 4th quarter. Stifel Financial Corp now owns 12,675 shares of the company's stock valued at $158,000 after purchasing an additional 2,450 shares during the last quarter. Institutional investors and hedge funds own 60.33% of the company's stock.

Indivior Trading Up 0.2%

NASDAQ INDV opened at $22.05 on Friday. The company has a fifty day simple moving average of $15.64 and a 200 day simple moving average of $12.17. The company has a market cap of $3.04 billion, a P/E ratio of 35.57 and a beta of 0.74. Indivior PLC has a 1 year low of $7.33 and a 1 year high of $22.33.

Indivior (NASDAQ:INDV - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.25. The business had revenue of $302.00 million during the quarter, compared to the consensus estimate of $239.43 million. Indivior had a net margin of 6.65% and a negative return on equity of 86.28%. Equities research analysts forecast that Indivior PLC will post 1.22 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on INDV shares. Jefferies Financial Group started coverage on shares of Indivior in a research report on Tuesday, July 22nd. They set a "buy" rating and a $20.00 target price on the stock. Wall Street Zen upgraded Indivior from a "buy" rating to a "strong-buy" rating in a research note on Saturday, June 21st. Craig Hallum raised their price objective on Indivior from $15.00 to $22.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Finally, HC Wainwright initiated coverage on Indivior in a research report on Wednesday. They set a "buy" rating and a $27.00 target price for the company. Five investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $19.60.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Want to see what other hedge funds are holding INDV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Indivior PLC (NASDAQ:INDV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.